Guadecitabine increases response to combined anti-CTLA-4 and anti-PD-1 treatment in mouse melanoma in vivo by controlling T-cells, myeloid derived suppressor and NK cells

Adriana Amaro, Michela Croce|Journal of Experimental & Clinical Cancer Research|2023

Cited by 26